© Reuters. EU Commissioner von der Leyen holds a press conference on plans to combat COVID-19 variants
BRUSSELS (Reuters) – European Commission President Ursula von der Leyen said Thursday the EU allows export of COVID-19 vaccines, mainly from BionTech / Pfizer and Modern (NASDAQ 🙂 while the United States and Britain had mechanisms to block them.
Von der Leyen said at a press conference that around 95% of the EU vaccines exported since January 30 have been manufactured by Pfizer (NYSE 🙂 and BioNTech and the rest of Moderna.
She said that both are adhering to their supply contracts with the EU and therefore have no export restrictions, while the EU is “keeping a very close eye” on AstraZeneca (NASDAQ 🙂 ‘s exports because of the company’s supply bottlenecks in the 27-nation bloc.
Von der Leyen added that there were systems in place in the US and UK that were effectively blocking the export of COVID-19 vaccines.
Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and Forex prices are not provided by exchanges, but by market makers. Therefore, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media assumes no liability for any loss or damage caused by reliance on the information contained on this website such as data, offers, charts and buy / sell signals. Please inform yourself comprehensively about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.